SCHEMBL24081135

SCHEMBL24081135

CCc1ccc(C=N)c(NC)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPA1 O75762 1/20 0.39
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2A6 P11509 1/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ PLK1 P53350 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ HRH4 Q9H3N8 1/20 0.31
▸ HRH3 Q9Y5N1 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ USP2 O75604 1/20 0.30
▸ GAA P10253 1/20 0.30
▸ ALOX15 P16050 1/20 0.30
▸ ALOX12 P18054 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26473856 0.85 TRPA1 (0.39) TRPA1CYP1A2CYP2A6NPC1RAB9A
SCHEMBL19382047 0.77 HDAC8 (0.41) CYP1A2RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL25665126 0.76 TRPA1 (0.43) TRPA1CYP1A2CYP2A6NPC1RAB9A
SCHEMBL4905317 0.75 TRPA1 (0.43) TRPA1CYP1A2CYP2A6NPC1RAB9A
SCHEMBL14303655 0.75 LMNA (0.37) CYP1A2CYP2A6ALDH1A1MAPTLMNA
SCHEMBL14345794 0.75 TRPA1 (0.59) TRPA1CYP1A2CYP2A6NPC1RAB9A
SCHEMBL12966316 0.73 LMNA (0.33) SMN1; SMN2ALDH1A1LMNAKCNH2HRH3
SCHEMBL17177427 0.73 ALDH1A1 (0.35) RAB9ASMN1; SMN2ALDH1A1MAPTLMNA
SCHEMBL8222799 0.73 NPC1 (0.43) TRPA1CYP1A2CYP2A6NPC1RAB9A
SCHEMBL13754339 0.72 TRPA1 (0.40) TRPA1CYP1A2CYP2A6NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3919056-A1 COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN Global Blood Therapeutics, Inc. (US) 2021-12-08 — — EP disclosed
Send feedback